SCHEMBL13445016

SCHEMBL13445016

O=C1C=Cc2c(S)cccc2C1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRC P08575 6/20 0.49
PTPN1 P18031 8/20 0.47
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
IDO1 P14902 4/20 0.47
KDM4E B2RXH2 4/20 0.47
MAPT P10636 4/20 0.47
THRB P10828 3/20 0.47
RECQL P46063 3/20 0.47
ALDH1A1 P00352 3/20 0.47
HPGD P15428 3/20 0.47
LMNA P02545 2/20 0.47
BCHE P06276 2/20 0.47
POLB P06746 2/20 0.47
CES1 P23141 2/20 0.47
PTPN22 Q9Y2R2 2/20 0.47
ALOX15 P16050 2/20 0.47
HSD17B10 Q99714 2/20 0.47
PKM P14618 1/20 0.47
ACHE P22303 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10409093 0.75 MAPT (0.53) PTPRCPTPN1MEN1KMT2AIDO1
SCHEMBL5886239 0.75 PTPRC (0.53) PTPRCPTPN1MEN1KMT2AIDO1
SCHEMBL30496126 0.75 MAPT (0.53) PTPRCPTPN1MEN1KMT2AIDO1
SCHEMBL8600436 0.75 PTPRC (0.49) PTPRCPTPN1MEN1KMT2AIDO1
SCHEMBL5886422 0.75 PTPRC (0.49) PTPRCPTPN1MEN1KMT2AIDO1
SCHEMBL5886509 0.75 PTPRC (0.49) PTPRCPTPN1MEN1KMT2AIDO1
SCHEMBL27921312 0.72 PTPRC (0.46) PTPRCPTPN1MEN1KMT2AIDO1
SCHEMBL7899015 0.72 PTPRC (0.46) PTPRCPTPN1MEN1KMT2AIDO1
SCHEMBL2400017 0.71 PTPRC (0.45) PTPRCPTPN1MEN1KMT2AIDO1
SCHEMBL5886287 0.71 TOP1 (0.58) PTPRCPTPN1MEN1KMT2AIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100098630-A1 Phenazine and Quinoxaline Substituted Amino Acids and Polypeptides AMBRX, INC. (US) 2010-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100098630-A1 Phenazine and Quinoxaline Substituted Amino Acids and Polypeptides PTMS, NPEPPS, DNPEP PTPRC 801/4885PTPN1 202/4885MEN1 2733/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.